Skip to content
RevolutionEyes

Condition

Dry age-related macular degeneration

Age-related macular degeneration affects the macula, the central part of the retina used for sharp, detailed vision. This is the vision needed for reading, recognising faces, driving and seeing fine detail.

Arrange an assessmentfrom £150
Treatment
Photobiomodulation only
Each session
About 12 minutes
Course
9 home sessions over 3 weeks
Assessment
In clinic, before and after

What we ask you to look for

Dry AMD is the more common form. It develops gradually as retinal cells and supporting tissues age and become less efficient. Waste deposits called drusen can build up beneath the retina. Over time, some people develop areas of retinal thinning, known as geographic atrophy.

Dry AMD does not usually cause complete blindness because side vision often remains. Even so, the impact can be serious. Losing central vision can make familiar tasks tiring or unsafe.

Lines as they should lookHow macular change can look
This is the Amsler grid, the chart used in clinic and at home to check central vision. You cover one eye, look at the centre dot, and report anything that looks bent, blurred or missing. Drag the handle to see what people with macular change often describe. This is an illustration, not a representation of any individual patient or of treatment results. If lines start to look wavy, seek advice promptly.

Symptoms people describe

  • Blurred or fuzzy central vision
  • Difficulty reading small print, even with glasses
  • Distorted or missing areas in central vision
  • Slower adjustment between bright and dim spaces
  • Colours appearing less vivid than they used to
  • Needing more light for close work

How we approach dry AMD

Every patient is assessed before any treatment is discussed. Your assessment includes vision testing and detailed macular scans where appropriate, so that any change over your treatment course can be measured rather than guessed at.

Where photobiomodulation is suitable, it is the only treatment used. Each home session takes around 12 minutes, and the aim is to support the cells at the back of the eye that matter for your sight. PBM is not a cure for AMD and it cannot restore vision that has already been lost. It is one part of a wider plan that still includes regular eye examinations and prompt referral if anything changes.

The Revolux photobiomodulation device held to the eyes, with red therapy light visible

How the treatment works

MitochondriaRed & near-infrared lightdelivered in controlled dosesRetinaPupil
  1. 1

    Selected wavelengths

    Red and near-infrared light is delivered in controlled doses. Unlike a surgical laser, it does not cut, burn or remove tissue.

  2. 2

    Absorbed by the cell

    The light reaches the mitochondria, the structures that produce most of the energy a cell needs to function.

  3. 3

    Energy and inflammation

    Research suggests certain wavelengths interact with cytochrome c oxidase, part of the mitochondrial energy pathway.

  4. 4

    Supported tissue

    The aim is not to boost cells in a vague sense. It is to help stressed cells work more normally and resist further damage.

Common questions

Your first and final assessments take place in a clinical setting, where the diagnostic equipment lives. That is what allows us to take detailed macular scans and compare them properly at the end of your course.

See all questions

Ready to talk it through?

Every patient is assessed before treatment is discussed. If PBM is not right for you, we will tell you.

Arrange an assessmentLearn about dry eye

The information on this site is for general guidance only and is not medical advice. Diagnosis and treatment decisions should always be made with a qualified eye care professional. If your vision changes suddenly, seek urgent advice.